The Food and Drug Administration announced it is making more than a dozen changes to improve oversight of prescription drugs, including increased monitoring of drugs' safety after they are on the market. FDA Commissioner Dr. Andrew Von Eschenbach discusses the…
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.